Skip to content
★ Sign in to follow
RP

R. Peters

Pharming Group N.V.
Insider activity · 24 months2 buys0 sales
Total declarations
7
Company
1
▲ Purchases (7 ops.)
—
▼ Sales (0 ops.)
—

Latest filing: trade of 28 May 2026 for Pharming Group N.V.. The register gives no publication date.

Filing timeline

BuySale
R. Peters

Insider track record

Disclosed buys
7
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
7

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

R. Peters: trading record in brief

R. Peters is a declared insider of Pharming Group N.V., with filings sourced from AFM. We count 7 filings; the first trade dates from 31 October 2023 and the latest from 28 May 2026.

The open-market record is one-sided, with 7 purchases and not one sale. The amount is not disclosed for 7 filings. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2026, the count stands at 1 purchase and no sales.

On 6 June 2026 came the latest disclosure, an open-market purchase in Pharming Group N.V. Every figure here comes from the filings published by AFM and describes the past, not future prices; it is not investment advice.

Companies and markets linked to R. Peters

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations7 total
  • ▲
    Director or Supervisory BoardExecutivesAFM delayPharming Group N.V.
    0AFM
    51,444 shares0Gewoon aandeelAFM:194918
    Canonical exit: 26 Aug 2026 (T+90)
  • ▲
    Director or Supervisory BoardExecutivesAFM delayPharming Group N.V.
    0AFM
    41,867 shares0Gewoon aandeelAFM:176241
    Canonical exit: 8 Sept 2025 (T+90)
  • ▲
    Director or Supervisory BoardExecutivesAFM delayPharming Group N.V.
    0AFM
    11,316 shares0Gewoon aandeelAFM:165345
    Canonical exit: 29 Jan 2025 (T+90)
  • ▲
    Director or Supervisory BoardExecutivesAFM delayPharming Group N.V.
    0AFM
    11,316 shares0Gewoon aandeelAFM:161779
    Canonical exit: 30 Oct 2024 (T+90)
  • ▲
    Director or Supervisory BoardExecutivesAFM delayPharming Group N.V.
    0AFM
    12,739 shares0Gewoon aandeelAFM:159036
    Canonical exit: 27 Aug 2024 (T+90)
  • ▲
    Director or Supervisory BoardExecutivesAFM delayPharming Group N.V.
    0AFM
    9,891 shares0Gewoon aandeelAFM:155751
    Canonical exit: 13 Jun 2024 (T+90)
  • ▲
    Director or Supervisory BoardExecutivesAFM delayPharming Group N.V.
    0AFM
    17,613 shares0Gewoon aandeelAFM:149917
    Canonical exit: 29 Jan 2024 (T+90)

7 of 7 declarations